NASDAQ:SRAX • US78472M1062
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SRAX INC (SRAX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-01-13 | B. Riley Securities | Maintains | Buy |
| 2022-09-26 | Dawson James | Maintains | Buy |
| 2021-04-19 | Dawson James | Initiate | Buy |
| 2021-02-08 | Ladenburg Thalmann | Initiate | Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.58M -63.77% | 8.65M 141.62% | 26.707M 208.75% | 29.967M 12.21% | 28.999M -3.23% | |
| EBITDA YoY % growth | -16.7M -52.37% | -10.3M 38.32% | 834K 108.10% | 9.618M 1,053.24% | 7.9M -17.86% | |
| EBIT YoY % growth | -17.86M -52.39% | -11.6M 35.05% | -85K 99.27% | -1.659M -1,851.80% | 117.81K 107.10% | |
| Operating Margin | -498.88% | -134.10% | -0.32% | -5.54% | 0.41% | |
| EPS YoY % growth | N/A | N/A | -1.16 13.84% | 0.29 124.58% | 0.31 8.05% |
All data in USD
| Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 92.14% | 0.08 155.08% | 0.09 146.16% | 0.02 -87.20% | 0.04 321.62% | 0.03 -58.02% | 0.03 -71.27% |
| Revenue Q2Q % growth | 9.69M 26.22% | 9.945M 19.63% | 7.905M 49.86% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 2.242M 816.29% | 2.214M 565.13% | 2.666M -45.89% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -466.14K 56.39% | -262.65K 83.56% | 373.32K -90.69% | N/A | N/A | N/A | N/A |
All data in USD
9 analysts have analysed SRAX and the average price target is 6.73 USD. This implies a price increase of 1022% is expected in the next year compared to the current price of 0.6.
SRAX INC (SRAX) will report earnings on 2023-04-03.
The consensus EPS estimate for the next earnings of SRAX INC (SRAX) is -0.02 USD and the consensus revenue estimate is 9.69M USD.
The consensus rating for SRAX INC (SRAX) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.